TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2015

A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.

Yujie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.